GSK GSK plc

1759.00GBp-1.15%Mkt Cap: 76.61B $P/E: 14.91

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…

Key Statistics

Company
Market Cap76.61B USD
Enterprise Value93.50B USD
Revenue (TTM)36.09B USD
Gross Profit25.71B USD
Net Income (TTM)6.21B USD
Revenue/Share8.26 GBp
Last Price1759.00 GBp
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.8K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)14.91
P/E (Forward)9.34
PEG5.73
EV/EBITDA7.95
EV/Revenue2.59
P/S2.15
P/B4.04
EPS (TTM)1.18
EPS (Forward)1.91
52W Range
1455.0037% of range2282.00
52W High2282.00 GBp
52W Low1455.00 GBp
Profitability
Gross Margin72.40%
Oper. Margin30.94%
EBITDA Margin32.58%
Profit Margin17.50%
ROE34.90%
ROA9.35%
Growth
Revenue Growth5.30%
Earnings Growth-69.50%
Cash Flow & Leverage
Operating CF8.41B USD
CapEx (TTM)3.24B USD
FCF Margin10.49%
FCF Yield4.94%
Net Debt16.51B USD
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity1.08
Current Ratio0.81
Quick Ratio0.52
Book Value/Sh4.40 GBp
Cash/Share0.78 GBp
Dividends
Fwd Div Rate0.68 GBp
Trail. Div Rate0.68 GBp
Div. Yield3.82%
5Y Avg Yield4.13%
Payout Ratio56.64%
Ex-Div DateAug 13, 2026
Pay Date—
Splits
Last Split4:5
Split DateJul 19, 2022
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2174.81 GBp
Upside (mean)+23.6%
Target Range1455.00 GBp – 3010.00 GBp
1455.00+23.6% to mean3010.00
# Analysts21
Ownership
Shares Out.4.01B
Float3.88B
Insiders1.75%
Institutions49.12%
Technical
SMA 501879.10 (-6.4%)
SMA 2001957.38 (-10.1%)
Beta0.29
S&P 52W Chg14.58%
Avg Vol (30d)5.56M
Avg Vol (10d)6.57M
Technical Indicators
RSI (14)33.3
MACD-23.6032
MACD Signal-13.7724
MACD Hist.-9.8308
BB Upper1934.95 GBp
BB Middle1846.10 GBp
BB Lower1757.25 GBp
BB Width9.63%
ATR (14)44.72 GBp
Vol Ratio (20d)0.62x